Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity
ConclusionHuman UC-MSCs and UC-MSCs-exo improved disease characterization of SS in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Yao Zou,
Wei Xiao,
Dongzhou Liu,
Xianyao Li,
Lihua Li,
Lijuan Peng,
Ying Xiong,
Haina Gan,
Xiang Ren Tags: ORIGINAL ARTICLE Source Type: research
More News: Allergy & Immunology | Diabetes | Endocrinology | Sjogren's Syndrome | Stem Cell Therapy | Stem Cells | Study